Matthew Jenusaitis
CIK 1357864 · Sr VP & Pres, Neuro Division · last filed 2025-12-15
Matthew Jenusaitis is a Sr VP & Pres, Neuro Division who has filed 15 SEC Form 4 insider transactions across 4 companies since 2007. The most recent filing, for NVNO, was dated Dec 15, 2025. Across all open-market trades the lifetime net is −$17.1K, making them a net seller over the disclosed history. Current disclosed insider exposure totals $3.5K across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Charts
Trading activity, where the exposure sits, and each trade against the stock price.
EVVV price and trades
Daily close with each Form 4 filing on this company marked: green = open-market buy, red = open-market sale, purple = grants, exercises, gifts and other non-market transactions. Marker size scales with the dollar value.
Shares held
Shares owned after each reported transaction on this company (direct holdings as reported).
Open-market buying and selling
by monthDollar value of open-market purchases (code P, up) and sales (code S, down) across all companies, by filing month. Grants, exercises and gifts are excluded.
Exposure by company
latestMost recently reported shares × current price. Faded bars (*) have had no filing in 3 years, so the person may no longer hold them. Click a bar to chart that company.
Filer Profile
IRVINE, CA 92618
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| NVNO | Director | 473 | $7.47 | $3.5K | $24.3K | 4 | 2025-12-15 |
| enVVeno Medical Corp (NVNOW) Delisted | Director | 6,925 | $0.01 | $44 | $0 | 3 | 2022-12-02 |
| enVVeno Medical Corp (HJLIW) Delisted | Director | 5,884 | $0.56 | $3.3K | $10.0K | 4 | 2021-09-15 |
| ev3 Inc. (EVVV) Delisted | Sr VP & Pres, Neuro Division | 58,002 | — | — | -$51.5K | 4 | 2008-05-02 |
Recent Filings
15 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2025-12-15 | NVNO | Grant (A) | — | $0 | EDGAR |
| 2024-12-23 | NVNO | Buy (P) | +9,620 | $24.3K | EDGAR |
| 2024-12-20 | NVNO | Grant (A) | — | $0 | EDGAR |
| 2023-12-07 | NVNO | Grant (A) | — | $0 | EDGAR |
| 2022-12-02 | enVVeno Medical Corp (NVNOW) Delisted | Grant (A) | — | $0 | EDGAR |
| 2022-09-16 | enVVeno Medical Corp (NVNOW) Delisted | Exer (M) | +1,041 | $0 | EDGAR |
| 2021-12-02 | enVVeno Medical Corp (NVNOW) Delisted | Grant (A) | — | $0 | EDGAR |
| 2021-09-15 | enVVeno Medical Corp (HJLIW) Delisted | Exer (M) | +1,042 | $0 | EDGAR |
| 2021-08-27 | enVVeno Medical Corp (HJLIW) Delisted | Buy (P) | +1,300 | $10.0K | EDGAR |
| 2021-02-22 | enVVeno Medical Corp (HJLIW) Delisted | Grant (A) | — | $0 | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.